Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. (Q51171870)

31 March 2018

title

Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. (English)

1 reference

31 March 2018

author name string

R S Kahn

1

1 reference

31 March 2018

S Wetzler

2

1 reference

31 March 2018

G M Asnis

3

1 reference

31 March 2018

M A Kling

4

1 reference

31 March 2018

R F Suckow

5

1 reference

31 March 2018

H M van Praag

6

1 reference

31 March 2018

publication date

1 January 1990

1 reference

31 March 2018

number of pages

6

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

31 March 2018

volume

100

1 reference

31 March 2018

issue

3

1 reference

31 March 2018

page(s)

339-344

1 reference

31 March 2018

https://scigraph.springernature.com/pub.10.1007/bf02244603

exact match

0 references

cites work

Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

Functional correlates of serotonin 5-HT1 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

Research diagnostic criteria: rationale and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244603

Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans

21 January 2018

1 reference

12 December 2020

Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans

1 reference

12 December 2020

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome

1 reference

12 December 2020

Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety.

1 reference

12 December 2020

Serotonin-releasing effects of substituted piperazines in vitro

1 reference

12 December 2020

Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys

1 reference

12 December 2020

Disposition and pharmacological effects of m-Chlorophenylpiperazine in rats

1 reference

12 December 2020

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

1 reference

12 December 2020

Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats.

1 reference

12 December 2020

Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors

1 reference

12 December 2020

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

1 reference

12 December 2020

Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion.

1 reference

12 December 2020

(—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone

1 reference

12 December 2020

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.

1 reference

12 December 2020

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

1 reference

12 December 2020

Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat.

1 reference

12 December 2020

The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity

1 reference

12 December 2020

Possible 5-hydroxytryptamine1 (5-HT1) receptor involvement in the stimulus properties of 1-(m-trifluoromethylphenyl)piperazine (TFMPP).

1 reference

12 December 2020

Hyper- and hyposensitivity of central serotonin receptors:[3H]serotonin binding and functional studies in the rat

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244603

1 reference

31 March 2018

1 reference

31 March 2018